Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Has Biotech Bottomed Out--and is Recent Recovery Sustainable? A look at the driving factors behind renewed optimism.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • المؤلفون: RYAN, BARBARA
  • المصدر:
    Pharmaceutical Executive. Aug2022, Vol. 42 Issue 8, p14-14. 1p.
  • معلومة اضافية
    • الموضوع:
      OPTIMISM; GOING public (Securities); SHORT selling (Securities)
    • نبذة مختصرة :
      The article highlights that e XBI biotech index could be close to a bottom following the longest and steepest decline since its inception whereas on May 11, the XBI traded as low as $62.81, a level it essentially retested one month later on June 14, 2022. It also discusses that The innovation renaissance remains underway across the sector, and the pace of progress for newer bleeding-edge technologies offering the promise of step-function improvements in patient outcomes.